Member Info for djwall1s

Well, WY, if there's a faint hope of getting our money back I'll hold out for it while the hope is there.

Footnote: Insulting other holders makes you look sad rather than the hero you wish you were.

Not sure, Rosewall. It might be the website's general policy.

I'm hoping ANA will release a video or podcast of the most recent meeting.

25-Jun-21 08:12:33 0.844 15,950 Sell* 0.80 0.90 134.62 O
25-Jun-21 08:03:05 0.844 220,500 Sell* 0.80 0.90 1,861 O

Definitely not sells.

Ye gads, why isn't this system simple!
Is it too much to ask to provide accurate detail in 2021, lol?
It's so misleading to the uninitiated.

Thanks for your take bigmj. Good to see you still keeping an eye on the forum.

I have no clue which way this will go but nice to see you are still sounding confident.

It's in the lap of the gods now I guess.

https://uk.advfn.com/stock-market/AQSE/ananda-developments-ANA/share-news/Ananda-Developments-Plc-Shareholder-Update/85443688

PS: I know nothing specific. Just that I think a few may need a pick me up after this crypto debacle.

Cannabis much safer proposal imo!

Pile into cannabis companies, that's all I can say.

You're very welcome.

He's well aware of the disgruntlement and has been for a long time.
It appears to be water off a duck's back.
I think we're due an update end of the month. Let's see where the goalposts are then.

I'll say what I said on the Tally forum to Kris, that whilst I'm not in any way blaming Tally staff (they don't make the corporate decisions), the company is still wondering why it's being blighted by social media dissent. I don't personally hold with online abuse and making things worse than they are, especially when there's a slim chance we might, might get a result. Though no guarantee.

They waste so much damn time though. What are they even doing right now? It's very hard to get anything concrete out of them and we've all tried. It'd be such a simple task for CP to dip into his own deep pockets and just relist u on Aquis or AIM for a fraction of the main market listing, and yet were still in limbo and no closer to anything. They just don't seem to have a concept of urgency, or how foolish they look dragging this on and being refused entry to platforms because of their own inaction over this period.

It's in the lap of the gods now. I do think they could relist Tally and get it firing but I don't think CP is the man to take it forward any more. A fresh team and a new boss could bang this out in no time. If Glint can come back from virtual oblivion, with whatever metrics (or not) and still got their Seedrs funding after their disastrous and highly criticised start, I think we can. But the fly in the ointment is now CP, unfortunately. I just can't see any way round him leaving and new management drafted in to remove the stink of the past. It won't happen, of course. But I think if they did that we' have half a chance. Unless CP really can pull a rabbit out of a hat at the last minute. It's just very hard to get a clear impression. We're left dangling but the company is still active and functioning, with staff (also shareholders) claiming all is well. Would they need to be so loyal if they were ****ed off and didn't have to be? Kris, Damon, any of these could up and move to any other London fintech atm, it's booming. So why do they stay in a dud? If it is wholly a dud?

So many questions.

There's no need, there's one already. Just type Oxford Cannabinoids into Telegram and up it pops.

CANNABIS INVEST UK

@AnandaPlc
CEO Melissa Sturgess to present at Cannabis Invest UK, bringing together investors and companies active in the cannabis and psychedelics industries Register for the event below on June 24th, 2021

REGISTER: https://www.bloompoint.co.uk/london

https://twitter.com/AnandaPlc/status/1403265510456836096

Thanks Rosewall. I'll post again, now and then, if there are things of interest. Sadly, Twitter is now a main channel of info nowadays, it's something I wish wasn't, but hey...

Anyway, it's been good to see more faces round here posting. Some day we might be less under the radar and have more forum users. GL.

*your own*

Okay, I'll not share on topic info again and folks can do your homework.

And enjoy a blank board some days. Not a problem.

https://twitter.com/OxCanTech/status/1400741470911483904

"Drug Science's research shows a child using medical cannabis has a 96% chance of have significant reduction in seizures & related health problems

The findings have been shared with Matt Han****"

https://twitter.com/AnandaPlc/status/1400721402907566087

Fri, 4th Jun 2021 07:00

RNS Number : 7967A
Oxford Cannabinoid Tech.Holdings
04 June 2021

RNS Reach

Oxford Cannabinoid Technologies Holdings plc
Company presentation webinar to retail investors

Oxford Cannabinoid Technologies Holdings plc (LSE: OCTP), a UK based pharmaceutical company focussed on developing cannabinoid-based prescription medicines approved by regulatory agencies, is pleased to announce that its CEO, Dr. John Lucas, and Executive Chairman, Neil Mahapatra, will conduct two live presentations to retail investors following its recent admission to trading on the Main Market of the London Stock Exchange.



The presentations will provide an opportunity for potential investors to learn about the Company and its outlook for the year ahead.

The live webinars, hosted by AJ Bell/Shares and Yellowstone Advisers, will take place on Tuesday 8th June 2021 at 19.45 and Thursday 10 June 2021 at 13.00, respectively.

The online presentations are open to all existing and potential investors and registration is free. Questions can be submitted during the presentation and will be addressed at the end.
To register, please go to:
- AJ Bell/Shares - https://www.sharesmagazine.co.uk/events/event/shares-investor-evening--webinar-080621

- Yellowstone - https://www.yellowstoneadvisory.com/event-details/oxford-cannabinoid-technologies-plc-webinar

For more information please contact:
Oxford Cannabinoid Technologies Holdings plc - Dr John Lucas (CEO)
079 5687 3125 / john@oxcantech.com

Nearly ten o' clock and nobody's noticed this RNS?
This thing really is under the radar.

Tue, 1st Jun 2021 07:00

RNS Number : 3070A
Oxford Cannabinoid Tech.Holdings
01 June 2021

1 June 2021

OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

("OCTP" or the "Company")

Consultancy Agreement with Voisin Consulting SARL

Oxford Cannabinoid Technologies Holdings plc, a UK based pharmaceutical company focussed on developing cannabinoid-based prescription medicines approved by regulatory agencies is pleased to announce that on 28 May 2021, it entered into a new consultancy agreement with Voisin Consulting SARL (trading as Voisin Consulting Life Sciences) ("VCLS"), a consulting team with more than 200 professionals in the UK, Europe, US and India, with expertise in medical devices, cannabinoids, neurological disorders and addiction, in order to:

(1) support and develop a regulatory strategy and roadmap for the UK and the US markets as a priority and consider potential subsequent delelopment in the EU;

(2) provide a high level nonclinical gap analysis of the Company's development plan to support First Time in Humans (FTiH) clinical trials; and

(3) provide a high level review of the Company's clinical development plan in relation to FTiH studies planned in patients;

in relation to the Company's drug development of lead compound OCT461201 in the areas of post-herpetic neuralgia and visceral pain due to irritable bowel syndrome.

OCTP has previously engaged VCLS on regulatory matters relating to the development of its phytocannabinoid (an unmodified naturally occurring cannabinoid) drug candidate.

Dr John Lucas, Chief Executive Officer of OCTP, said: "we are delighted to continue to partner with Voisin Consulting Life Sciences in our quest to deliver life-changing therapies for severe pain. OCT, which recently listed on the London Stock Exchange (LSE: OCTP), wants its innovative strategy to have the necessary depth in strength and quality which is crucial to deliver a much-needed product that is both safe and efficacious. Our management team is determined to do the right thing for its patients and we believe that a consultancy firm like VCLS can provide us with best-in-class support. As a consequence of our early discussions with the VCLS team, it became clear that their expertise, knowledge, and quality meant they were the partners we were looking for."

Emmanuelle M Voisin, Founder and CEO of Voisin Consulting Life Sciences, said: "we are thrilled to be partnering with Oxford Cannabinoid Technologies at this important stage, to support it on its exciting journey to become the global leader in developing cannabinoid-based prescription medicines. I am delighted that OCTP has chosen Voisin Consulting Life Sciences to facilitate its delivery of innovative, life-changing pain medication."

A very good interview imo:

https://twitter.com/StockBoxMedia/status/1398957359599390721

If it gets us our money back, go for it I say.